Throat spray and hydroxychloroquine found to reduce risk of Covid-19 infection: Singapore study
Photo - Reuters The Straits Times The Straits Times
Using a throat spray or consuming the anti-malaria drug hydroxychloroquine has been found to reduce the risk of Covid-19 infection in healthy individuals in areas with high transmission rates.
These findings were revealed by a local study of more than 3,000 healthy young migrant workers who were quarantined in Tuas South Dormitory in May last year.
The study found that taking a povidone-iodine throat spray three times a day, or the oral drug hydroxychloroquine once daily, reduced the likelihood of getting infected by Sars-CoV-2, the virus that causes Covid-19, by over 20 percent.
Anti-malaria drug, throat spray found to cut Covid-19 infection risk
straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.
Throat spray and hydroxychloroquine found to reduce risk of Covid-19 infection: Singapore study-549388
daily-sun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daily-sun.com Daily Mail and Mail on Sunday newspapers.
Benefits found in throat spray and hydroxychloroquine
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.